These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
948 related articles for article (PubMed ID: 28191776)
41. Human umbilical cord Wharton's jelly-derived mesenchymal stem cells differentiate into a Schwann-cell phenotype and promote neurite outgrowth in vitro. Peng J; Wang Y; Zhang L; Zhao B; Zhao Z; Chen J; Guo Q; Liu S; Sui X; Xu W; Lu S Brain Res Bull; 2011 Feb; 84(3):235-43. PubMed ID: 21194558 [TBL] [Abstract][Full Text] [Related]
42. The dose effect of human bone marrow-derived mesenchymal stem cells on epidermal development in organotypic co-culture. Laco F; Kun M; Weber HJ; Ramakrishna S; Chan CK J Dermatol Sci; 2009 Sep; 55(3):150-60. PubMed ID: 19564098 [TBL] [Abstract][Full Text] [Related]
43. An update on human periapical cyst-mesenchymal stem cells and their potential applications in regenerative medicine. Ayoub S; Berbéri A; Fayyad-Kazan M Mol Biol Rep; 2020 Mar; 47(3):2381-2389. PubMed ID: 32026284 [TBL] [Abstract][Full Text] [Related]
44. Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells. Strioga M; Viswanathan S; Darinskas A; Slaby O; Michalek J Stem Cells Dev; 2012 Sep; 21(14):2724-52. PubMed ID: 22468918 [TBL] [Abstract][Full Text] [Related]
45. The Human Umbilical Cord Tissue-Derived MSC Population UCX(®) Promotes Early Motogenic Effects on Keratinocytes and Fibroblasts and G-CSF-Mediated Mobilization of BM-MSCs When Transplanted In Vivo. Miranda JP; Filipe E; Fernandes AS; Almeida JM; Martins JP; De la Fuente A; Abal M; Barcia RN; Cruz P; Cruz H; Castro M; Santos JM Cell Transplant; 2015; 24(5):865-77. PubMed ID: 24480602 [TBL] [Abstract][Full Text] [Related]
46. The human kidney capsule contains a functionally distinct mesenchymal stromal cell population. Leuning DG; Engelse MA; Lievers E; Bijkerk R; Reinders MEJ; de Boer HC; van Kooten C; Rabelink TJ PLoS One; 2017; 12(12):e0187118. PubMed ID: 29206835 [TBL] [Abstract][Full Text] [Related]
47. Comparison of molecular profiles of human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue. Heo JS; Choi Y; Kim HS; Kim HO Int J Mol Med; 2016 Jan; 37(1):115-25. PubMed ID: 26719857 [TBL] [Abstract][Full Text] [Related]
48. Mesenchymal stromal cells; a new horizon in regenerative medicine. Tavakoli S; Ghaderi Jafarbeigloo HR; Shariati A; Jahangiryan A; Jadidi F; Jadidi Kouhbanani MA; Hassanzadeh A; Zamani M; Javidi K; Naimi A J Cell Physiol; 2020 Dec; 235(12):9185-9210. PubMed ID: 32452052 [TBL] [Abstract][Full Text] [Related]
50. [Mesenchymal stem cells and regenerative medicine: future perspectives in osteoarthritis]. Maumus M; Pers YM; Ruiz M; Jorgensen C; Noël D Med Sci (Paris); 2018 Dec; 34(12):1092-1099. PubMed ID: 30623767 [TBL] [Abstract][Full Text] [Related]
51. Human Glioblastoma-Derived Mesenchymal Stem Cell to Pericytes Transition and Angiogenic Capacity in Glioblastoma Microenvironment. Yi D; Xiang W; Zhang Q; Cen Y; Su Q; Zhang F; Lu Y; Zhao H; Fu P Cell Physiol Biochem; 2018; 46(1):279-290. PubMed ID: 29590646 [TBL] [Abstract][Full Text] [Related]
52. Transforming growth factor-β1-overexpressing mesenchymal stromal cells induced local tolerance in rat renal ischemia/reperfusion injury. Cai J; Jiao X; Zhao S; Liang Y; Ning Y; Shi Y; Fang Y; Ding X; Yu X Cytotherapy; 2019 May; 21(5):535-545. PubMed ID: 30685215 [TBL] [Abstract][Full Text] [Related]
53. Toll-like receptor 2/6-dependent stimulation of mesenchymal stem cells promotes angiogenesis by paracrine factors. Grote K; Petri M; Liu C; Jehn P; Spalthoff S; Kokemüller H; Luchtefeld M; Tschernig T; Krettek C; Haasper C; Jagodzinski M Eur Cell Mater; 2013 Sep; 26():66-79; discussion 79. PubMed ID: 24027020 [TBL] [Abstract][Full Text] [Related]
54. Combined use of bone marrow-derived mesenchymal stromal cells (BM-MSCs) and platelet rich plasma (PRP) stimulates proliferation and differentiation of myoblasts in vitro: new therapeutic perspectives for skeletal muscle repair/regeneration. Sassoli C; Vallone L; Tani A; Chellini F; Nosi D; Zecchi-Orlandini S Cell Tissue Res; 2018 Jun; 372(3):549-570. PubMed ID: 29404727 [TBL] [Abstract][Full Text] [Related]
56. Comprehensive Effects of Suppression of MicroRNA-383 in Human Bone-Marrow-Derived Mesenchymal Stem Cells on Treating Spinal Cord Injury. Wei GJ; Zheng KW; An G; Shi ZW; Wang KF; Guan Y; Wang YS; Li PF; Dong DM Cell Physiol Biochem; 2018; 47(1):129-139. PubMed ID: 29763918 [TBL] [Abstract][Full Text] [Related]
57. The adipose-derived lineage-negative cells are enriched mesenchymal stem cells and promote limb ischemia recovery in mice. Qin Y; Zhou P; Zhou C; Li J; Gao WQ Stem Cells Dev; 2014 Feb; 23(4):363-71. PubMed ID: 24083854 [TBL] [Abstract][Full Text] [Related]
58. Bone mesenchymal stem cells ameliorate ischemia/reperfusion-induced damage in renal epithelial cells via microRNA-223. Yuan X; Wang X; Chen C; Zhou J; Han M Stem Cell Res Ther; 2017 Jun; 8(1):146. PubMed ID: 28619106 [TBL] [Abstract][Full Text] [Related]
59. Regenerative medicine in kidney disease: where we stand and where to go. Borges FT; Schor N Pediatr Nephrol; 2018 Sep; 33(9):1457-1465. PubMed ID: 28735502 [TBL] [Abstract][Full Text] [Related]
60. Regeneration of cartilage and bone by defined subsets of mesenchymal stromal cells--potential and pitfalls. Aicher WK; Bühring HJ; Hart M; Rolauffs B; Badke A; Klein G Adv Drug Deliv Rev; 2011 Apr; 63(4-5):342-51. PubMed ID: 21184789 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]